What is she best known for?
The fields of study she is best known for:
- Cancer
- Gene
- Internal medicine
Irene M. Ghobrial spends much of her time researching Internal medicine, Multiple myeloma, Bone marrow, Bortezomib and Cancer research.
Irene M. Ghobrial combines subjects such as Gastroenterology, Surgery and Oncology with her study of Internal medicine.
Her Multiple myeloma research also works with subjects such as
- Immune system, which have a strong connection to Plasma cell,
- Resorption most often made with reference to Bone resorption.
Her Bone marrow research is multidisciplinary, relying on both Osteoclast, Stromal cell, Haematopoiesis and Cell biology.
Her Bortezomib research incorporates themes from Proteasome inhibitor, Lenalidomide, Dexamethasone, Pharmacology and PLGA.
Her Cancer research study integrates concerns from other disciplines, such as Apoptosis, microRNA, Stem cell, CD19 and Gene silencing.
Her most cited work include:
- Biological properties of extracellular vesicles and their physiological functions (2028 citations)
- BET Bromodomain Inhibition as a Therapeutic Strategy to Target c-Myc (1959 citations)
- Targeting apoptosis pathways in cancer therapy. (1045 citations)
What are the main themes of her work throughout her whole career to date?
Her scientific interests lie mostly in Internal medicine, Multiple myeloma, Cancer research, Bone marrow and Bortezomib.
Her Internal medicine research includes elements of Gastroenterology, Surgery and Oncology.
The various areas that Irene M. Ghobrial examines in her Multiple myeloma study include Monoclonal gammopathy of undetermined significance, Clinical trial, Disease and Transplantation.
Her Cancer research research focuses on Cell growth and how it relates to Cell cycle.
The study incorporates disciplines such as Tumor microenvironment, Cell culture and In vivo in addition to Bone marrow.
Her Bortezomib research is multidisciplinary, incorporating elements of Proteasome inhibitor, Phases of clinical research, Neutropenia, Dexamethasone and Pharmacology.
She most often published in these fields:
- Internal medicine (40.62%)
- Multiple myeloma (43.11%)
- Cancer research (33.87%)
What were the highlights of her more recent work (between 2017-2021)?
- Multiple myeloma (43.11%)
- Cancer research (33.87%)
- Internal medicine (40.62%)
In recent papers she was focusing on the following fields of study:
Irene M. Ghobrial mainly investigates Multiple myeloma, Cancer research, Internal medicine, Oncology and Bone marrow.
Her Multiple myeloma research includes themes of Disease progression, Computational biology and Monoclonal gammopathy of undetermined significance.
Her research in the fields of Tumor microenvironment overlaps with other disciplines such as Extramural.
Her research in Internal medicine focuses on subjects like Gastroenterology, which are connected to Waldenstrom macroglobulinemia and Asymptomatic.
Her Oncology study deals with Cancer intersecting with Haematopoiesis.
Irene M. Ghobrial has researched Bone marrow in several fields, including Tumor progression and In vitro.
Between 2017 and 2021, her most popular works were:
- Risk of COVID-19 among front-line health-care workers and the general community: a prospective cohort study. (394 citations)
- The BTK inhibitor ibrutinib may protect against pulmonary injury in COVID-19-infected patients. (126 citations)
- The BTK inhibitor ibrutinib may protect against pulmonary injury in COVID-19-infected patients. (126 citations)
In her most recent research, the most cited papers focused on:
- Cancer
- Gene
- Internal medicine
Her primary areas of study are Multiple myeloma, Cancer research, Internal medicine, Bone marrow and Oncology.
Her studies in Multiple myeloma integrate themes in fields like Disease progression, Haematopoiesis, Cancer, Tolerability and Neutropenia.
In general Cancer research, her work in Tumor microenvironment is often linked to Extramural linking many areas of study.
As a part of the same scientific family, she mostly works in the field of Internal medicine, focusing on Gastroenterology and, on occasion, Waldenstrom macroglobulinemia, Asymptomatic and Macroglobulinemia.
Her research in Bone marrow intersects with topics in Monoclonal gammopathy of undetermined significance, In vitro, Disease, Mesenchymal stem cell and Bone remodeling.
Her studies deal with areas such as Previously treated, Clinical trial and Stem cell as well as Oncology.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
